Literature DB >> 32427961

Differentiated exophytic vulvar intraepithelial lesion: Clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva.

Amir Akbari1, Andre Pinto2, Yutaka Amemiya3, Arun Seth1,3, Jelena Mirkovic1, Carlos Parra-Herran4.   

Abstract

Verruciform proliferations of the vulva unrelated to HPV infection are rare. The term differentiated exophytic vulvar intraepithelial lesion (DEVIL) was recently proposed for these lesions, which harbor recurrent PIK3CA mutations. It is still unclear whether DEVIL is related to verrucous carcinoma, a neoplasm characterized by persistence and local recurrence but nil risk of distant spread. Specimens identified using the words "verruciform" and "verrucous" were reviewed. Diagnosis of DEVIL required verruciform acanthosis, hyper and/or parakeratosis, hypogranulosis, cytoplasmic pallor, and bland nuclei. Verrucous carcinoma required, in addition, discontinuous, bulbous, puzzle-like nests in the stroma. A targeted next-generation sequencing using a custom 11-gene panel was performed. Eighteen specimens corresponding to ten patients with DEVIL and/or verrucous carcinoma were included. Median age at presentation was 66 years for DEVIL and 70 years for verrucous carcinoma. A similar spectrum of prevalent mutations was found in both lesions involving HRAS, PIK3CA, and BRAF. DEVIL preceded verrucous carcinoma and/or was diagnosed concurrently or in subsequent follow-up in five patients. In four of these, the same mutation was identified in DEVIL and synchronous or metachronous carcinoma. All cases showed wild-type 53 staining and lacked pathogenic TP53 mutations. DEVIL is a rare form of squamous proliferation characterized by prevalent PIK3CA and HRAS mutations. Its temporal relationship with verrucous carcinoma and their shared mutational profile in some patients suggest that DEVIL is a precursor of verrucous carcinoma. Moreover, given their morphologic and molecular overlap and the nil risk of verrucous carcinoma for distant spread, it is conceivable that DEVIL and verrucous carcinoma represent a spectrum of the same entity.

Entities:  

Mesh:

Year:  2020        PMID: 32427961     DOI: 10.1038/s41379-020-0573-5

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  5 in total

1.  Analysis of h-ras, k-ras and N-ras genes for expression, mutation and amplification in laryngeal tumors.

Authors:  H Kiaris; D Spandidos
Journal:  Int J Oncol       Date:  1995-07       Impact factor: 5.650

2.  Induction of cyclin D1 overexpression by activated ras.

Authors:  J Filmus; A I Robles; W Shi; M J Wong; L L Colombo; C J Conti
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

3.  Verrucous carcinoma of the genital tract: is it a distinct entity?

Authors:  D I Robertson; R Maung; M A Duggan
Journal:  Can J Surg       Date:  1993-04       Impact factor: 2.089

4.  Human papilloma virus in verrucus carcinoma of the vulva: an immunopathological study of three cases.

Authors:  A Kondi-Paphitis; H Deligeorgi-Politi; A Liapis; M Plemenou-Frangou
Journal:  Eur J Gynaecol Oncol       Date:  1998       Impact factor: 0.196

5.  Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.

Authors:  Basile Tessier-Cloutier; Jennifer Pors; Emily Thompson; Julie Ho; Leah Prentice; Melissa McConechy; Rosalia Aguirre-Hernandez; Ruth Miller; Samuel Leung; Lily Proctor; Jessica N McAlpine; David G Huntsman; C Blake Gilks; Lynn N Hoang
Journal:  Mod Pathol       Date:  2020-08-13       Impact factor: 7.842

  5 in total
  3 in total

1.  Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma.

Authors:  Abeer M Salama; Amir Momeni-Boroujeni; Chad Vanderbilt; Marc Ladanyi; Robert Soslow
Journal:  Mod Pathol       Date:  2021-10-14       Impact factor: 8.209

Review 2.  Molecular events in the pathogenesis of vulvar squamous cell carcinoma.

Authors:  Deyin Xing; Oluwole Fadare
Journal:  Semin Diagn Pathol       Date:  2020-09-25       Impact factor: 3.464

Review 3.  The Vulvar Cancer Risk in Differentiated Vulvar Intraepithelial Neoplasia: A Systematic Review.

Authors:  Féline O Voss; Nikki B Thuijs; Ravi F M Vermeulen; Erica A Wilthagen; Marc van Beurden; Maaike C G Bleeker
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.